Ann: Imugene doses first patient in nextHERIZON Phase 2 trial, page-37

You love to see it, Imugene don't hide anything and stand by their clinical trials and treatments!
Publication of our results provides transparency.
It's sad to say but so many pharmaceutical companies do not publish their clinical trial results and if they do its 10 years or so later. When clinical trial information is kept hidden, it means governments and regulators are at risk of making the wrong decisions for patients.

By publishing this information, it provides a reference point for what has and what hasn't worked in the past - Instead of reinventing the wheel and potentially endangering patients.